The 23rd International
Annual Congress of the
World Muscle Society

Teaching Course

WMS Pre-Congress Teaching Course: 1-2 October 2018

The 16th WMS course will be held at The Institute of Histology and Embryology by Dr. Mario H. Burgos, CCT Conicet Mendoza.
Please note only 50 places are available. Early booking is advised.

Teaching objectives: To improve the diagnostic competence of professionals dealing with patients with neuromuscular diseases.

Target audience: Medical specialists (paediatricians, neurologists, paediatric neurologists, geneticists, neuropathologists) and medical specialists in training, and other attendees of the WMS congress.

REGISTER NOW      VIEW THE PROGRAMME

For all registration queries please contact registrationargentina@mci-group.com

Course description

The emphasis of this course will be on the clinical approach of patients who present with symptoms of a neuromuscular disease. The course will be entirely practical and case reports will be presented to highlight key clinical concepts. There will be the opportunity to discuss the integrated diagnostic approach to patients shown on video, to look at muscle MRI imaging, neurophysiology, or muscle biopsies.

Generous time will be allowed for questions from the audience, and for discussion of difficult topics.

For this purpose, each participant will be asked to bring one neuromuscular case to be presented and discussed. For every case each participant should prepare 2 PowerPoint slides:

Slide 1 should contain a clinical picture/clinical video demonstrating major clinical characteristics (onset; clinical course; CK; NCV; heredity; other)

Slide 2 should contain one pertinent piece of information (e.g. muscle or brain imaging; a family tree; immunofluorescence or Western blot data)

Please bring a maximum of 5 Powerpoint slides on a memory stick showing the most salient muscle biopsy findings. Slides should be loaded onto the main course computer prior to the beginning of the course or during breaks.

The presentation should not take longer than 3 minutes.

Participants should be able to better recognise a number of important neuromuscular presentations; incorporate up-to-date diagnostic approaches to the patient suspected of a neuromuscular disease; consider the differential diagnosis; apply appropriate tests.



Course Speakers

Fabio Barroso

Fabio Barroso
Argentina

Bio coming soon.


Carsten Bönnemann

Carsten Bönnemann
USA

Carsten Bönnemann graduated from Medical School at the University of Freiburg in Germany. He trained in pediatrics in Hamburg and Göttingen (where he was awarded the habilitation/venia legendi in pediatrics), and in neurology/child neurology at Massachusetts General Hospital/Harvard Medical School in Boston. He did postdoctoral research in genetics and neuromuscular specialty training at Boston Children’s Hospital/Harvard Medical School. From 2002 he was on the faculty as Co-Director of the Neuromuscular Program and Director of the Pediatric Neurogenetics Clinic at Children’s Hospital of Philadelphia/University of Pennsylvania School of Medicine, where he continues to be on faculty as Adjunct Full Professor of Neurology. In 2010 he was recruited to the NIH as a tenured Senior Investigator and Chief of the Neuromuscular and Neurogenetic Disorders of Childhood Section in the Neurogenetics Branch of the National Institute of Neurological Disorders and Stroke. Clincal, genomic and translational laboratory work in the Section centers in particular around early onset neuromuscular disorders such as the congenital myopathies and congenital muscular dystrophies and on the development of molecular and gene based treatment approaches to these condition. Dr Bönnemann was a Pew Fellow in the Biomedical Sciences and in 2010 received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association. He is Co-Editor-in-Chief of the Journal of Neuromuscular Diseases (JND). He has authored more then 200 papers, reviews and chapters in the field of pediatric neuromuscular and neurogenetic disorders.


Max Damian

Maxwell Damian, PhD, FNCS
UK

Consultant in Neurology and Neurocritical Care at Cambridge University Hospitals and Ipswich Hospital, UK, with subspecialty areas in Muscle Disease, Neurophysiology and Neurocritical Care for clinical work and research. Co-Chair of the Neurocritical Care Panel of the European Academy of Neurology. Fellow of the Neurocritical Care Society (USA). Previously worked in Germany and Australia. Born in Hobart, Tasmania. Medical School in Mainz, Germany and London, UK.


Soledad Monges

Soledad Monges
Argentina

  • Pediatric Neurology, Hospital de Pediatría “Prof. Dr. Juan P. Garrahan” dedicated to the management of patients with neuromuscular disease, since 2005.
  • Coordinator of the study group and treatment of neuromuscular disease at the Hospital de Pediatría “Prof. Dr. Juan P. Garrahan” since 2006.
  • Exchange Project Ecos-Secyt (2003-2005)Clinical, Genetic, and Morphological Characterization of Congenital Centronuclear and Central Core Myopathies: Phenotype-Genotype Correlation. Institute of Myology, Paris and Hospital de Pediatría “Prof. Dr. Juan P. Garrahan”
  • Exchange Project MINCYT-MICINN: Genetic characterization of Argentinean Spinal Muscular Atrophy patients.Servicio de Genética Hospital Sant Pau, Barcelona and Hospital de Pediatría J.P. Garrahan (ongoing)


Anders Oldfors

Anders Oldfors
Sweden

Professor of Pathology, Department of Pathology and Genetics, Institute of Biomedicine, University of Gothenburg, combined with appointment as Senior Consultant in Surgical Pathology, at Sahlgrenska University Hospital.


Anna Sarkozy

Anna Sarkozy
UK

Anna Sarkozy works as a consultant in neuromuscular at the Dubowitz Neuromuscular Centre in London, UK. Anna has a background in clinical and molecular genetics. In addition to her role as a clinician, Anna has a special research interest in  myopathies and muscular dystrophies with congenital onset and is particularly interested in clarifying phenotypes of new or rare forms of neuromuscular diseases, identifying their genetic causes and elucidating possible genotype-phenotype correlations.


Benedikt Schoser

Benedikt Schoser
Germany

Benedikt Schoser started his career at the lab of Hans Goebel in 1990. He was trained in Neurology, Neurological intensive care, palliative medicine, psychiatry, and neurophysiology at the Universities Mainz, Frankfurt, and Hamburg, Germany. He obtained his Habilitation in 2004. He is senior consultant neurologist and co-chair of the Friedrich-Baur- Institute. His research interests are translational therapy of multisystemic neuromuscular diseases.


Werner Stenzel

Werner Stenzel
Germany

Werner Stenzel is Professor of Neuropathology and Neuroimmunology at the Charité University hospital in Berlin, Germany. He is a board certified Neurologist and Neuropathologist with strong interest in muscle patholgy and pathophysiology as well as inflammatory mechanisms of neuromuscular diseases. Werner serves as member of the executive board for WMS.


Peter Van den Bergh

Peter Van den Bergh
Belgium

Professor of Neurology, Director Neuromuscular Reference Centre, Head EMG Lab, Head Neuromuscular Pathology Lab.


John Vissing

John Vissing
Denmark

Professor John Vissing is Director of the Copenhagen Neuromuscular Center at the National Hospital in Copenhagen. He has authored more than 300 scientific articles on muscle disease, and his research focusses on developing diagnostic tests and treatments for patients with muscle diseases.

Copyright © WMS Congress Ltd

For further information please contact the Congress Secretariat:
MCI ARGENTINA Av. Córdoba 883, Piso 11 Ciudad de Buenos Aires, Argentina Mobile: +54 9 351 539 9631

MCI